Here, the production and characterization of mAbs against CD8 T lymphocytes were successfully achieved; furthermore, the comparative immune responses between CD4 and CD8 T cells after viral infection and immuno-stimulation were investigated using these newly generated mAbs. This evidence concerns the gene CD8A and viral infectious disease.